PL1664315T3 - Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów - Google Patents

Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów

Info

Publication number
PL1664315T3
PL1664315T3 PL04774913T PL04774913T PL1664315T3 PL 1664315 T3 PL1664315 T3 PL 1664315T3 PL 04774913 T PL04774913 T PL 04774913T PL 04774913 T PL04774913 T PL 04774913T PL 1664315 T3 PL1664315 T3 PL 1664315T3
Authority
PL
Poland
Prior art keywords
gene therapy
vivo gene
rheumatoid arthritis
aav vectors
virions
Prior art date
Application number
PL04774913T
Other languages
English (en)
Inventor
Paul Peter Tak
Christian Jorgensen
Original Assignee
Acad Medisch Ct
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Medisch Ct, Inst Nat Sante Rech Med filed Critical Acad Medisch Ct
Publication of PL1664315T3 publication Critical patent/PL1664315T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PL04774913T 2003-09-01 2004-09-01 Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów PL1664315T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL0300611 2003-09-01
PCT/NL2004/000607 WO2005021768A1 (en) 2003-09-01 2004-09-01 Aav vectors for in vivo gene therapy of rheumatoid arthritis
EP04774913A EP1664315B1 (en) 2003-09-01 2004-09-01 Aav vectors for in vivo gene therapy of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
PL1664315T3 true PL1664315T3 (pl) 2012-09-28

Family

ID=34270790

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04774913T PL1664315T3 (pl) 2003-09-01 2004-09-01 Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów

Country Status (10)

Country Link
EP (2) EP1664315B1 (pl)
JP (1) JP4863874B2 (pl)
AT (1) ATE556140T1 (pl)
AU (1) AU2004269279B2 (pl)
CA (1) CA2536471C (pl)
DK (1) DK1664315T3 (pl)
ES (1) ES2384975T3 (pl)
PL (1) PL1664315T3 (pl)
PT (1) PT1664315E (pl)
WO (1) WO2005021768A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090104155A1 (en) * 2006-04-21 2009-04-23 Goodrich Laurie R Treatment of connective tissue disorders
CN118048321A (zh) 2016-01-13 2024-05-17 建新公司 用于治疗哺乳动物内骨关节炎和相关关节病症的表达骨保护性基因、包括has2和润滑素的重组aav载体
HUE062774T2 (hu) * 2018-01-17 2023-12-28 Meiragtx Uk Ii Ltd Módosított rAAV kapszidfehérje génterápiához
WO2023183623A1 (en) 2022-03-25 2023-09-28 Regenxbio Inc. Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US6046319A (en) 1997-10-22 2000-04-04 University Technologies International, Inc. Antisense oligodeoxynucleotides regulating expression of TNF-α
ATE402254T1 (de) * 1998-05-28 2008-08-15 Us Gov Health & Human Serv Aav5 vektoren und deren verwendung
CA2374597A1 (en) * 1999-05-28 2000-12-07 Targeted Genetics Corporation Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
JP4827353B2 (ja) * 1999-08-09 2011-11-30 ターゲティッド ジェネティクス コーポレイション 鎖内塩基対を形成するような配列の設計による、組換えウイルスベクターからの一本鎖の異種ヌクレオチド配列の発現の増大
US20040191221A1 (en) * 2001-05-22 2004-09-30 Keiya Ozawa Methods of treating skeletal disorders using recombinant adeno-associated virus virions
US20030003583A1 (en) * 2001-06-08 2003-01-02 Raphael Hirsch Regulation of transgene expression following AAV transduction
WO2003093440A2 (en) * 2002-04-30 2003-11-13 University Of Florida Methods and compositions for expressing a nucleic acid in a dendritic cell

Also Published As

Publication number Publication date
PT1664315E (pt) 2012-07-31
DK1664315T3 (da) 2012-07-09
AU2004269279B2 (en) 2010-02-25
JP4863874B2 (ja) 2012-01-25
CA2536471A1 (en) 2005-03-10
EP1664315A1 (en) 2006-06-07
ES2384975T3 (es) 2012-07-16
WO2005021768A1 (en) 2005-03-10
EP2322638A1 (en) 2011-05-18
ATE556140T1 (de) 2012-05-15
EP1664315B1 (en) 2012-05-02
CA2536471C (en) 2013-10-08
JP2007504219A (ja) 2007-03-01
AU2004269279A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
HK1071518A1 (en) Improved raav expression systems for genetic modification of specific capsid proteins
DE69929600D1 (de) Konvektion-erhöhte verabreichung aadc-kodierende aav vektoren
MXPA03010079A (es) Formulaciones de oxicodona de administracion una vez al dia.
ATE444361T1 (de) Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2003042362A3 (en) PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
MXPA05013526A (es) Secuencias de acido nucleico que codifican y composiciones que comprenden el peptido de senal de ige y/o il-15 y metodos para uso de los mismos.
EP1546343A4 (en) PRODUCTION OF RECOMBINANT AAV HIGH TITER
PL1664315T3 (pl) Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
WO2002008257A3 (en) Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
WO2002016591A3 (en) Human transporter family members and uses thereof
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
AU2002359572A8 (en) 15603, a human ion channel family member
WO2002044357A3 (en) Methods of using 18903 to treat pain and pain-related disorders
WO2004013281A3 (en) Novel proteins and their uses
DE60237236D1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
WO2002077190A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2003074675A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2003031463A3 (en) 14081, a human trypsin-like serine protease family member and uses therefor
WO2003038040A3 (en) 32235, a human aminotransferase family member and uses therefor
WO2003038110A3 (en) 7118, a human arginine n-methyltransferase family member and uses therefor
WO2003030616A3 (en) 21132, a human g-protein coupled receptor family member and uses therefor